Caffeine is quickly absorbed through the gastrointestinal tract [1–3], and moves through cellular membranes with the same efficiency that it is absorbed and circulated to tissue [4, 5]. Caffeine (1,3,7-trimethylxanthine) selleck compound is metabolized by the liver and through enzymatic action results in three metabolites: paraxanthine, theophylline, and theobromine [1, 6–8]. Elevated levels can appear in the bloodstream within 15-45 min of consumption, and peak concentrations are evident one hour post ingestion [1, 3, 9, 10]. Due to its lipid solubility, caffeine also crosses the blood-brain barrier without difficulty

[5, 11]. Meanwhile, caffeine and its metabolites are excreted by the kidneys, with approximately 3-10% expelled from the body unaltered in urine [1, 7, 12]. Based on tissue uptake and urinary clearance circulating concentrations are decreased by 50-75% within 3-6 hours of consumption [3, 13]. Thus, clearance from the bloodstream is analogous to the rate at which caffeine is absorbed Selleck Ku-0059436 and metabolized. Multiple mechanisms have been proposed to explain the effects of caffeine supplementation on sport performance. However, several extensive reviews

have stated that the most significant mechanism is that caffeine acts to compete with adenosine at its receptor sites [5, 13, 14]. In fact, in an exhaustive review of caffeine and sport performance, it was stated that “”because caffeine crosses the membranes of nerve and muscle cells, its effects may be more neural than muscular. Even if caffeine’s main effect is muscular, it may have more powerful effects at steps other than metabolism in the process of exciting and contracting the muscle [15]“”. Clearly, one of caffeine’s primary sites of action is the central nervous system (CNS). Moreover, theophylline and paraxanthine can also contribute to the pharmacological effect on the CNS through specific signaling pathways [5]. However, as noted above, Smoothened rarely is there a single mechanism that fully

explains the physiological effects of any one nutritional supplement. Because caffeine easily crosses the blood brain barrier as well as cellular membranes of all tissues in the body [15], it is exceedingly difficult to determine in which system in particular (i.e. nervous or skeletal muscle) caffeine has the greatest effect [15]. In addition to its impact on the CNS, caffeine can affect substrate utilization during exercise. In particular, research findings suggest that during exercise caffeine acts to decrease reliance on glycogen utilization and increase dependence on free fatty acid mobilization [16–19]. Essig and colleagues [19] reported a significant increase in intramuscular fat oxidation during leg ergometer cycling when subjects consumed caffeine at an approximate dose of 5 mg/kg. Additionally, Spriet et al.

In this study, we hypothesize that the direct intra-tumoral injection of zinc could be a safe and efficacious treatment for prostate cancer. To our knowledge, this is the first examination of intra-tumoral zinc delivery as a treatment strategy for prostate cancer, and we feel that these data form powerful preliminary evidence indicating that such a minimally invasive strategy could be efficacious. Furthermore, because of the preferential accumulation of Saracatinib price zinc in prostate tissue, it is conceivable that such a strategy could be entirely free of the debilitating and dose-limiting side effects typical of other cancer chemotherapeutics. Methods Cell lines

PC3, DU148, LNCaP cells were originally obtained from ATCC (Rockville, Maryland, USA). Cells were maintained at 37°C, 5% CO2 and 95% humidity in DMEM (CellGro, Herndon, Virginia, USA)

supplemented with 10% (v/v) heat inactivated fetal bovine serum (BioWhittaker, Walkersville, Maryland, selleck chemicals USA), 2 mM L-glutamine and 100 units/ml penicillin and 1000 ug/ml streptomycin (Invitrogen, Carlsbad, California, USA). Animals NOD/SCID mice at 8 weeks of age were purchased from Charles River Laboratories (Wilmington, Massachusetts, USA) and were housed at the Saint Louis University comparative medicine facility. Animals were allowed to acclimate for 2 weeks prior to experimentation. The animals were under the care of a staff veterinarian and managed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Xenografts PC3 cells grown to 70% confluence were harvested and injected in the dorsum of animals subcutaneously. Each inoculum consisted of 100 μL of cell suspension at a concentration of 107 cells/ml in phosphate-buffered saline. Tumors were allowed to grow to a size of 300 mm3 prior to intra-tumoral PD-1 antibody inhibitor injection. Tumors were injected with 200 μL of 3 mM zinc acetate solution every 48 hours. Tumors were measured every 2–3 days with digital calipers. Tumor volume was determined using the following formula: Volume = Length × Width2. Zinc Measurements

Zinc was quantified in serum and tissues using the TSQ fluorophore (Invitrogen, Carlsbad, California, USA). 50 mM TSQ was prepared in 10 mM Tris buffer (ph = 8.0). TSQ was added to samples and standard zinc solutions to a final concentration of 10 μM in black round-bottom 96 well plates. Endpoint fluorescence was read on a Spectfluor with excitation wavelength of 360 nm and emission wavelength of 535 nm. Tissue zinc levels were measured similarly, after weighing and homogenizing tissue in water by repeated freeze/thaw cycles. MTT Assay Cell viability was determined via MTT assay. Briefly, media was aspirated from cells grown in 6 well plates and 1 ml of MTT (1 mg/ml) solution was added. After 1 hour incubation, MTT solution was aspirated and 0.04 N HCL was added to solubilize the cells and absorbance at 540 nM was measured.

An incident morphometric vertebral fracture was diagnosed by lateral and posterior–anterior chest and spinal X-rays using the semi-quantitative assessment [12], in which a decrease of at least 20% in height of any vertebral body from initial reading to the end of the study was defined as a morphometric vertebral fracture. Since the incidence of clinical vertebral fracture was not known in Japan, the ratio of clinical fracture to morphometric fracture incidence was assumed to be the same

in Japan as it was for Sweden when the Japanese version of FRAX® was developed, i.e. 30% of morphometric vertebral fractures were assumed as clinical fractures [24, 27]. Sweden The incidence rates of hip and clinical vertebral fractures for Swedish Caucasians were also obtained from a previously published study by Kanis et al., in which all incident fractures, including hip fractures (1991) and clinical vertebral fractures (1993 and 1994) were identified from files check details at the Department of Diagnostic Radiology in Malmo, Sweden, for the relevant year. Only vertebral fractures that came to clinical attention were captured, and subjects who previously sustained a fracture of the same type were excluded from analysis. The annual incidences of hip and clinical vertebral fractures were calculated for men and women by age [28]. Statistical analyses Baseline characteristics of the Chinese subjects are expressed in means ± SD for continuous

variables and in percentage for categorical variables. Time to incident hip or vertebral fractures was calculated according to the date of X-ray reports or physician’s consultations when the diagnosis ITF2357 mw was made. The average follow-up period for all subjects was 4.0 ± 2.8 (range, 1 to 14) years, with a total follow-up of 14,733 patient-years. Subjects who had received anti-osteoporosis medication after sustaining a fracture during the follow-up period or those who deceased at the time of analysis were analysed up to their time of treatment initiation or last contact Aspartate time point. Incidence rates were reported as rate per 100,000 person-years. The incidence rates of vertebral and hip fractures were compared to the published data from

Japan and Sweden. Vertebral-to-hip fracture ratios were used to demonstrate the proportion of vertebral fractures in relation to hip fractures in different populations. Results A total of 4,116 Southern Chinese subjects (2,302 women and 1,810 men) aged 50 or above were included in the analysis. The mean age at baseline was 62 ± 8.2 years for women and 68 ± 10.3 years for men. Of the women, 37.2% and 63.4% of men were above the age of 65 years. Baseline demographic information and characteristics are shown in Table 1. Of the men, 55.5% and 72.1% of women reported having difficulty bending forward, kyphosis, low back pain and/or height loss >2 cm since the age of 25. However, only 2.7% of men and 5.5% of women reported a history of past clinical vertebral fracture.

Phys Rev Lett 2011, 106:220402.CrossRef 6. Fu L, Kane CL: Superconducting proximity effect and www.selleckchem.com/products/bgj398-nvp-bgj398.html Majorana fermions at the surface of a topological insulator . Phys Rev Lett 2008, 100:096407.CrossRef 7. Tanaka Y, Yokoyama

T, Nagaosa N: Manipulation of the Majorana fermion, Andreev reflection, and Josephson current on topological insulators . Phys Rev Lett 2009, 103:107002.CrossRef 8. Klinovaja J, Gangadharaiah S, Loss D: Electric-field-induced Majorana Fermions in Armchair Carbon Nanotubes . Phys Rev Lett 2012, 108:196804.CrossRef 9. Read N, Green D: Paired states of fermions in two dimensions with breaking of parity and time-reversal symmetries and the fractional quantum Hall effect . Phys Rev B 2000, 61:10267.CrossRef 10. Potter AC, Lee PA: Majorana end states in multiband microstructures with Rashba spin-orbit coupling . Phys Rev B 2011, 83:094525.CrossRef 11. Wong CLM, Liu J, Law KT, Lee PA: Majorana flat bands and unidirectional Majorana edge states in gapless topological superconductors . Phys Rev B 2013, 88:060504(R).CrossRef 12. Chamon C, Hou C-Y, Mudry C, Ryu S, Santos L: Masses and Majorana fermions

in graphene . Phys. Scr 2012, T146:014013.CrossRef 13. Lutchyn RM, Sau JD, Das SS: Majorana fermions and a topological phase transition in semiconductor-superconductor heterostructures NVP-BEZ235 cell line . Phys Rev Lett 2010, 105:077001.CrossRef 14. Oreg Y, Refael G, von Oppen F: Helical liquids and Majorana bound states

in quantum wires . Phys Rev Lett 2010, 105:177002.CrossRef 15. Mourik V, Zuo K, Frolov SM, Plissard SR, Bakkers EPAM, Kouwenhoven LP: Signatures of Majorana fermions in hybrid superconductorsemiconductor nanowire devices . Science 2012, 336:1003.CrossRef 16. Deng MT, Yu CL, Huang GY, Larsson M, Caroff P, Xu HQ: Anomalous zero-bias conductance peak in a Nb-InSb Nanowire-Nb hybrid device . Nano Lett 2012, 12:6414.CrossRef 17. Das A, Ronen Y, Most Y, Oreg Y, Heiblum M, Shtrikman H: Zero-bias peaks and splitting in an Al-InAs nanowire topological superconductor as a signature of Majorana fermions . Nat Phys 2012, 8:887.CrossRef 18. Lee EJH, Jiang X, Aguado R, Katsaros G, Lieber CM, De FS: Zero-bias anomaly in a nanowire quantum dot coupled to superconductors . Phys Rev Lett 2012, 109:186802.CrossRef 19. Churchill HOH, Fatemi V, Grove-Rasmussen pheromone K, Deng MT, Caroff P, Xu HQ, Marcus CM: Superconductor-nanowire devices from tunneling to the multichannel regime: zero-bias oscillations and magnetoconductance crossover . Phys Rev B 2013, 87:241401.CrossRef 20. Rokhinson LP, Liu XY, Furdyna JK: The fractional a. c. Josephson effect in a semiconductor-superconductor nanowire as a signature of Majorana particles . Nat Phys 2012, 8:795.CrossRef 21. Law KT, Lee PA, Ng TK: Majorana fermion induced resonant Andreev reflection . Phys Rev Lett 2009, 103:237001.CrossRef 22.

Chem Phys AZD1152-HQPA in vivo Lett 2011, 504:71–75.CrossRef 14. Zhao L, Han M, Lian J: Photocatalytic activity of TiO 2 films with mixed anatase and rutile structures prepared by pulsed laser deposition. Thin Solid Films 2008, 516:3394–3398.CrossRef 15. Zhang J, Xu Q, Feng Z, Li M, Li C: Importance of the relationship between surface phases and photocatalytic activity of TiO 2 . Angew Chem Int Ed 2008, 47:1766–1769.CrossRef 16. Deák P, Aradi B, Frauenheim T: Band lineup and charge carrier separation in mixed rutile-anatase systems. J Phys Chem C 2011, 115:3443–3446.CrossRef 17. Ting

C-C, Chen S-Y, Liu D-M: Structural evolution and optical properties of TiO 2 thin films prepared by thermal oxidation of sputtered Ti films. J Appl Phys 2000, 88:4628–4633.CrossRef NU7441 18. DeLoach

JD, Scarel G, Aita CR: Correlation between titania film structure and near ultraviolet optical absorption. J Appl Phys 1999, 83:2377–2384.CrossRef 19. Tian J, Deng H, Sun L, Kong H, Yang P, Chu J: Influence of Ni doping on phase transformation and optical properties of TiO 2 films deposited on quartz substrates by sol–gel process. Appl Surf Sci 2012, 258:4893–4897.CrossRef 20. Tian J, Gao H, Deng H, Sun L, Kong H, Yang P, Chu J: Structural, magnetic and optical properties of Ni-doped TiO 2 thin films deposited on silicon(100) substrates by sol–gel process. J Alloy Compd 2013, 581:318–323.CrossRef 21. Bahadur N, Pasricha R, Govind , Chand S, Kotnala RK: Effect of Ni doping on the microstructure and high Curie temperature ferromagnetism in sol–gel derived titania powders. Mater Chem Phys 2012, 133:471–479.CrossRef 22. Tian J, Deng

H, Sun L, Kong H, Yang P, Chu J: Effects of Co doping on structure and optical properties of TiO 2 thin films prepared by sol–gel method. Thin Solid Films 2012, 520:5179–5183.CrossRef 23. Barakat MA, Hayes G, Shah SI: Effect of cobalt doping on the phase transformation of TiO 2 nanoparticles. J Nanosci Nanotechnol 2005, 5:759–765.CrossRef 24. Rath C, Mohanty P, Pandey AC, Mishra NC: Oxygen vacancy induced structural phase transformation in TiO 2 nanoparticles. J Phys D Appl Phys 2009, 42:205101.CrossRef 25. Moulder J, Stickle WF, Sobol PE, Bomben KD: Handbook of X-Ray Photoelectron Spectroscopy. L-gulonolactone oxidase 2nd edition. Eden Prairie, MN: Perkin Elmer Corporation (Physical Electronics); 1992:72–85. 26. Grosvenor AP, Biesinger MC, Smart RSC, McIntyre NS: New interpretations of XPS spectra of nickel metal and oxides. Surf Sci 2006, 600:1771–1779.CrossRef 27. Han SY, Lee DH, Chang YJ, Ryu SO, Lee TJ, Chang CH: The growth mechanism of nickel oxide thin films by room-temperature chemical bath deposition. J Electrochem Soc 2006, 153:C382-C386.CrossRef 28. Kallel W, Bouattour S, Ferreira LFV, Botelho do Rego AM: Synthesis, XPS and luminescence (investigations) of Li + and/or Y 3+ doped nanosized titanium oxide. Mater Chem Phys 2009, 114:304–308.CrossRef 29.

To provide a schematic graphical overview of DEAD-box sequence motif conservation, we performed a multiple sequence alignment for each motif and then used the WebLogo software to obtain a precise description of sequence similarity [37, 38] (Figure 1 – inset). Analysis of regions separating each pair

of consecutive motifs was consistent with the reported low sequence but high length conservation (Figure 1) [33, 34]. The DEAD-box family has an N-terminal length ranging from 2 to 233 amino acids and a C-terminal length from 29 to 507 amino acids, but lack any additional domain described in other DEAD-box proteins (Figure 1) [39]. In agreement with the analyses of Banroques [40], we found that almost 55% of Giardia AZD0530 putative DEAD-box helicases have an N-terminal length of 2-45 residues and a C-terminal length of 29-95 residues, whereas the size of the HCD containing the conserved motifs ranges between 331 and 403 residues in almost 70% of

this family sequences. Figure 1 Schematic diagram of the DEAD-box RNA helicase family in G. lamblia . Each motif is represented by a different color. The distances between the motifs, and the size of the N- and C- terminal extensions for each ORF, are indicated (number of aa). The AZD2281 mw red bars within the N- or C-terminal extensions represent the regions amplified with specific primers for the qPCR. The representation is to scale. Inset: sequence LOGO view of the consensus amino acids. The height of each amino acid represents the degree of conservation. Colors mark properties of the amino acids as follows: green (polar), blue (basic), red

(acidic) and black (hydrophobic). The DEAH-box family The 6 putative RNA helicases belonging to the DEAH-box family were analyzed by multiple sequence alignment and subsequent manual scanning, in search of conserved motifs characteristic of this family. As shown in Additional file 6: Figure S3, the 5 helicases present the eight characteristic motifs, with the exception of Clomifene GL50803_13200, which was incomplete in its N-terminal region, missing Motif I. As with the missing motif of DEAD-box helicase GL50803_34684, a new database search showed a homologous gene, GL50581_4549 from the isolate GS, with the complete N-terminal region that was used to search the isolate WB for the entire ORF. Surprisingly, this new putative 5´ DNA genomic region does not have a traditional ATG start codon; instead, there are two putative alternative initiation codons already described in rare cases for the fungus Candida albicans[41] or in mammalian NAT1 [42]. Studies in progress are analyzing this finding. The consensus sequence was obtained and was in agreement with the DEAH-box motifs published by Linder and Owttrim [43] (Figure 2 – inset).

aureus sbnA and sbnB genes are necessary for staphyloferrin B production. We have also shown that S. aureus mutations in sbnA and sbnB are fully complementable selleck chemicals llc in trans by both wild-type copies of each gene as well as through feeding of the molecule L-Dap itself, leading to the renewed production of the staphyloferrin

B molecule. The data support the contention that the enzymes SbnA and SbnB function synergistically as a L-Dap synthase, catalyzing the first committed biosynthetic step towards staphyloferrin B synthesis in S. aureus. Overall, this is the first study that simultaneously investigates the roles of both genes encoding a cohesive L-Dap synthase. The L-Dap molecule is a very unusual and rare amino acid. It is non-proteinogenic but it is often found structurally associated with secondary metabolites such as antibiotics (Table 4). To our knowledge, staphyloferrin B represents the only characterized siderophore that contains L-Dap as part of its structure (Figure 1A). The experiment shown in Figure 2A also reinforces the fact that only L-Dap, and not D-Dap, is incorporated into staphyloferrin B. This is in agreement with initial structural elucidation studies [15], GS1101 the high resolution crystal

structure of the siderophore [28], as well as enzymatic recognition of L-Dap as a substrate by staphyloferrin B NIS synthetases [17]. The only siderophore Arachidonate 15-lipoxygenase with a component similar to L-Dap in its structure is achromobactin

from Pseudomonas syringae [35], which has an overall structure and biosynthetic pathway that is very similar to that of staphyloferrin B. In place of L-Dap, achromobactin contains L-2,4-diaminobutyric acid which is condensed onto a unit of citrate and α-KG at both amino groups. L-2,4-diaminobutyric acid may be synthesized by a putative aminotransferase (AcsF) that is also encoded within the achromobactin biosynthetic gene cluster. In the case of achromobactin, synthesis of this diamino acid substrate requires only one enzyme as opposed to the two enzymes required for synthesis of L-Dap. Biochemical characterization of AcsF, along with its substrate specificity, awaits further investigation. Why some siderophore biosynthetic systems have evolved to select one diamino acid over another is an intriguing biological question. Based on bioinformatics and the emerging diversity of members of the OCD enzyme family, the S. aureus SbnB enzyme likely does not contribute to proline production, and hence would not recognize L-ornithine as a substrate. In agreement with this hypothesis, under the experimental conditions of Li et al. [36] in testing S.

Identifiers of EF1-α subgroups and intron configuration patterns Selleckchem Temsirolimus are indicated. Integration of intron insertion patterns and EF1-α phylogenetic distribution In order to assess the phylogenic distribution of the different

intron configuration types, they were mapped on the EF1-α tree (Figure 2). All 53 B. bassiana s.s. isolates showed an intron IC1 inserted at position 4. However, the IE intron inserted at position 1 was only present in the 10 isolates from subgroup Eu-7 and 33 out of 39 isolates from subgroup Wd-2. In particular, this subgroup included most of the Spanish isolates of B. bassiana forming an EF1-α phylogenetic group with isolates 681 from Romania and 792 from the USA [8] but displaying two different intron insertion models. Bb51 showed a unique intron insertion pattern, with an IC1 intron at position 2, and located separately in the Eu-9 subgroup. No introns were detected at any position in the three B. cf. bassiana isolates from clade C. No correlation between EF1-α phylogenetic groups and insect host was observed. Although Eu-7 subgroup did not included isolates of insect origin, the Wd-2 subgroup grouped isolates collected DAPT from Diptera, Hymenoptera, Lepidoptera and Orthoptera. Moreover, Wd-2

isolates from Orthoptera displayed different intron insertion models (i.e., Bb37, Bb39 and Bb40, and Bb42). Forty-nine Spanish and one Portuguese isolates of B. bassiana s.s. were collected from subtropical Mediterranean climate zones and were distributed

in the Eu-7, Eu-3, Wd-2 and Eu-8 subgroups. Two Spanish isolates, Bb52 and Bb53, were collected from continental climate locations and were placed within subgroups Eu-7 and Wd-2, respectively. many The only B. bassiana s.s. isolate from a humid oceanic climate included in this work, Bb51 from Santander, displayed a characteristic intron insertion model and formed the EF1-α subgroup Eu-9. In addition, Bb51 produced smaller conidia than the rest of B. bassiana isolates, this morphological feature being statistically significant (data not shown). Nevertheless, other isolate from the same climatic zone, Bb50, was grouped with other European isolates in B. cf. bassiana clade C. Discussion In the present study, we have identified different B. bassiana genotypes and phylogenetic subgroups in a collection of 57 isolates of this fungus, based on intron insertion patterns and EF1-α phylogenies, respectively. The variability in group I introns from rDNA genes has been used as a molecular tool for the identification of polymorphisms in entomopathogenic fungi [23, 30, 31]. Our study of B. bassiana LSU rDNA identified 99 introns among the 57 isolates analyzed. Four specific sites of intron insertion have been described previously in Beauveria species [23, 25], but in our collection introns were only detected at positions 1, 2 or 4. Particularly, our study shows that 100% of B. bassiana s.s. isolates had an intron inserted at position 4.

95) when compared to incubation without plasma (Figure 3), suggesting that the presence

of non-specific IgG does not alter the ability of hRS7 to mediate ADCC in Trop-2 expressing carcinosarcoma cells. Figure 3 Representative cytotoxicity experiments against the OMMT-ARK-2 cell line. Cytotoxicity in the presence of human plasma diluted 1:2 (with or without heat-inactivation) with effector cells and either hRS7 or rituximab control antibody in 5 h 51Cr-release assays. Addition of untreated plasma (diluted 1:2) to PBL in the presence of hRS7 significantly increased the ADCC achieved in the presence of hRS7 and PBL against OMMT-ARK-2 (P = 0.002). Addition of physiological concentrations of IgG (i.e. heat-inactivated plasma diluted 1:2) to PBL in the presence of hRS7 did not significantly alter the degree of ADCC achieved against OMMT-ARK-2 in the presence of hRS7 and PBL DAPT molecular weight (P = 0.95). Discussion In this study, we have investigated Trop-2 expression Selleckchem p38 MAPK inhibitor and localization by immunohistochemistry in uterine and ovarian carcinosarcomas and compared these findings to normal endometrium and ovarian control tissues. We have evaluated Trop-2 expression in multiple biologically aggressive, chemotherapy-resistant carcinosarcoma cell lines. Additionally, we have tested the sensitivity of these primary cell lines to immune-mediated cell death in the presence of hRS7, a humanized Trop-2 mAb made by grafting

the complementary-determining regions of its murine counterpart (mRS7) onto human IgG1 framework regions [11, 13–15]. To our knowledge, this is the first time that Trop-2 protein has been demonstrated to be significantly upregulated in human carcinosarcomas

from the uterus (UMMT) and ovary (OMMT), with negligible expression being detected in normal ovarian and uterine tissues. Significantly, Trop-2 positivity was confined to the epithelial component of the carcinosarcomas, without exception. Flavopiridol (Alvocidib) Although the relationship between high Trop-2 expression and the aggressiveness of human epithelial neoplasms remains unclear, there is evidence that Trop-2 functions in the transduction of cell signals regulating tumor cell growth and resistance to apoptosis. Trop-2 possesses cytoplasmic serine and tyrosine phosphorylation sites and might function as a cell signal transducer and regulator of tumor cell growth while increasing tumor cell resistance to apoptosis [16]. Consistent with this, Trop-2 has been identified as an oncogene, implicated in colon cancer tumor growth, migration, and invasion, which suggests that Trop-2- specific targeting may inhibit tumor cell growth, migration and invasion [17]. Several human cancers have been shown to express a bicistronic CYCLIN D1-TROP2 mRNA chimera that acts as an oncogene and is able to induce aggressive tumor growth [18]. These observations support the possibility that aberrant Trop-2 expression contributes to the enhanced biologic aggressiveness of multiple human cancers, including carcinosarcomas.

Conclusions In this paper, the total ionizing dose (TID) effect of 60Co γ ray radiation on Ag/AlO x /Pt RRAM devices has been investigated. Degradations of uniformity and performance are observed in resistance and switching voltage, which is caused by the radiation-induced holes. A hybrid filament model is proposed to suggest that holes are co-operated with Ag ions to build filaments. The model is proved by the thermal coefficients of resistivity in LRS. Moreover, the Ag/AlO x /Pt RRAM devices

demonstrate a satisfactory anti-radiation ability because of the stable resistive switching and a sufficient memory window. Acknowledgements This work was supported (in part) by the State Key Development Program for Basic Research of China (No. 2011CBA00602) and the National Natural Science Foundation of China (No. 20111300789). References 1. Waser R, Aono M: Nanoionic-based resistive switching

memories. Nat Mater this website 2007, 6:833–840. 10.1038/nmat2023CrossRef 2. Wu Y, Lee B, Wong HSP: Al 2 O 3 -based RRAM using atomic layer deposition (ALD) with 1-μA RESET current. IEEE Electron Device Lett 2010, 31:1449.CrossRef 3. Wong HSP, Lee HY, Yu S, Chen Y-S, Wu Y, Chen P-S, Lee B, Chen FT, Tsai M-J: Metal–oxide RRAM. Proc IEEE 2012, 100:1951.CrossRef 4. Prakash A, Maikap S, Chiu H-C, Tien T-C, Lai C-S: Enhanced resistive switching memory characteristics and mechanism using a Ti nanolayer at the W/TaO x interface. Nanoscale Res Lett 2013, 8:288. 10.1186/1556-276X-8-288CrossRef

Exoribonuclease 5. Yuan F, Wang J-C, Zhang ZG, Ye Y-R, Pan LY, Xu J, Lai C-S: Hybrid aluminum see more and indium conducting filaments for nonpolar resistive switching of Al/AlO x /indium tin oxide flexible device. Appl Phys Express 2014, 7:024204. 10.7567/APEX.7.024204CrossRef 6. Chen YY, Goux L, Clima S, Govoreanu B, Degraeve R, Kar GS, Fantini A, Groeseneken G, Wouters DJ, Jurczak M: Endurance/retention trade-off on HfO 2 /metal cap 1T1R bipolar RRAM. IEEE Trans Electron Devices 2013, 60:1114.CrossRef 7. Hsieh M-C, Liao Y-C, Chin Y-W, Lien C-H, Chang T-S, Chih Y-D, Natarajan S, Tsai M-J, King Y-C, Lin CJ: Ultra high density 3D via RRAM in pure 28nm CMOS process. In IEEE International Electron Devices Meeting. IEDM Technical Digest: 9–11 December 2013. Washington, DC: Piscataway: IEEE; 2013. 10.3.1 8. Srour JR, Marshall CJ, Marshall PW: Review of displacement damage effects in silicon devices. IEEE Trans Nucl Sci 2003, 50:653. 10.1109/TNS.2003.813197CrossRef 9. Paccagnella A, Candelori A, Milani A, Formigoni E, Ghidini E, Pellizzer F, Drera D, Fuochi PG, Lavale M: Breakdown properties of irradiated MOS capacitors. IEEE Trans Nucl Sci 1996, 43:2609. 10.1109/23.556843CrossRef 10. Miao B, Mahapatra R, Jenkins R, Silvie J, Wright NJ, Horsfall AB: Radiation induced change in defect density in HfO-based MIM capacitors. IEEE Trans Nucl Sci 2009, 56:2916.